Nordea Investment Management AB purchased a new position in shares of Mylan NV (NASDAQ:MYL) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 25,026 shares of the company’s stock, valued at approximately $916,000.
Other large investors have also modified their holdings of the company. Stratos Wealth Partners LTD. acquired a new position in shares of Mylan during the third quarter worth $183,000. Reilly Financial Advisors LLC lifted its holdings in shares of Mylan by 69.4% during the third quarter. Reilly Financial Advisors LLC now owns 5,217 shares of the company’s stock worth $191,000 after purchasing an additional 2,137 shares during the period. BB&T Corp acquired a new position in shares of Mylan during the third quarter worth $202,000. Sustainable Insight Capital Management LLC acquired a new position in shares of Mylan during the third quarter worth $226,000. Finally, Caxton Associates LP acquired a new position in shares of Mylan during the third quarter worth $247,000. Institutional investors own 82.16% of the company’s stock.
MYL stock opened at $29.87 on Wednesday. The firm has a market capitalization of $14.87 billion, a P/E ratio of 6.55, a PEG ratio of 0.87 and a beta of 1.57. The company has a current ratio of 1.26, a quick ratio of 0.77 and a debt-to-equity ratio of 1.20. Mylan NV has a 12-month low of $26.03 and a 12-month high of $47.82.
Mylan (NASDAQ:MYL) last posted its quarterly earnings results on Monday, November 5th. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.06. Mylan had a net margin of 4.71% and a return on equity of 19.39%. The firm had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.91 billion. During the same period in the previous year, the firm posted $1.10 earnings per share. The business’s revenue was down 4.2% compared to the same quarter last year. Equities analysts anticipate that Mylan NV will post 4.66 earnings per share for the current fiscal year.
MYL has been the topic of a number of recent research reports. ValuEngine lowered shares of Mylan from a “hold” rating to a “sell” rating in a report on Tuesday, September 11th. BidaskClub lowered shares of Mylan from a “hold” rating to a “sell” rating in a report on Wednesday, September 19th. Mizuho lowered shares of Mylan from a “buy” rating to a “neutral” rating in a report on Friday, October 5th. Morgan Stanley lowered shares of Mylan from an “overweight” rating to an “equal weight” rating and dropped their target price for the company from $46.00 to $36.00 in a report on Tuesday, October 9th. Finally, Zacks Investment Research upgraded shares of Mylan from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 9th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. Mylan currently has an average rating of “Buy” and a consensus price target of $45.76.
COPYRIGHT VIOLATION NOTICE: “Nordea Investment Management AB Purchases Shares of 25,026 Mylan NV (MYL)” was published by Stock Observer and is the property of of Stock Observer. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.thestockobserver.com/2019/01/09/nordea-investment-management-ab-purchases-shares-of-25026-mylan-nv-myl.html.
Mylan Company Profile
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.
Recommended Story: Leveraged Buyout (LBO)
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.